Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke

Current Medical Research and Opinion

Volumn 20, Issue 11, 2004, Pages 1845-1849

  Cavendish, Jeffrey J ^a   Cramer, Steven C ^b   Graham, Glenn D ^c  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Antiplatelet; Atherothrombosis; Ischemic stroke; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERIOGRAPHY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART INFARCTION; HEART LEFT RIGHT SHUNT; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY ARTERY STENOSIS; MALE; RECURRENT DISEASE; RISK FACTOR; SECONDARY PREVENTION; STENT; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE;

EID: 10044225585     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904X10674     Document Type: Article

References (23)

1. American Heart Association. Heart Disease and Stroke Statistics - 2004 Update. Report available online at: http: //www.americanheart.org/downloadable/ heart/1079736729696 HDSStats2004UpdateREV3-19-04.pdf [accessed 1 Sept 2004]
2. Rosamond WD, Folsom AR, Chambless LE, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999;30:736-43
3. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2004;126:483S-512S
4. Albers GW, Caplan LR, Easton JD, et al. Transient ischemic attack: proposal for a new definition. N Engl J Med 2002;347:1713-6
5. Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16(Suppl. 1):14-9
6. Johnston SC, Gress DR, Browner WS, et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901-6
7. Munger MA, Hawkins DW. Atherothrombosis: epidemiology, pathophysiology, and prevention. J Am Pharm Assoc 2004;44:S5-12;quiz S12-3
8. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13
9. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39
10. Ness J, Aronow WS. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1999;47:1255-6
11. Sacco RL, Shi T, Zamanillo MC, et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994;44:626-34
12. Hardie K, Hankey GJ, Jamrozik K, et al. Ten-year survival after first-ever stroke in the Perth community stroke study. Stroke 2003;34:1842-6
13. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86
14. Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry 1999;66:255
15. Ringleb PA, Bhatt DL, Hirsch AT, et al. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke 2004;35:528-32
16. Diener HC, Bogousslavsky J, Brass LM, et al. Management of Atherothrombosis with Clopidogrel in High-Risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke (MATCH): Study Design and Baseline Data. Cerebrovasc Dis 2004;17:253-61
17. Diener HC, Bogousslavsky J, Brass LM, et al. MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-7
18. Amarenco P, Donnan GA. Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin? Stroke 2004;35:2606-8
19. Cavendish JJ, Fugit RV, Safani M. Role of antiplatelet therapy in cardiovascular disease I: acute coronary syndromes. Curr Med Res Opin 2004;20(11):1839-43
20. Cavendish JJ, Safani M. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease, Curr Med Res Opin 2004;20(11):1851-55
21. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-6
22. Alberts MJ. Hyperacute stroke therapy with tissue plasminogen activator. Am J Cardiol 1997;80:29D-34D;discussion 5D-9D
23. Reed SD, Cramer SC, Blough DK, et al. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832-40